HLS Therapeutics Liabilities 2024

HLS Therapeutics Aktienanalyse

What does HLS Therapeutics do?

HLS Therapeutics Inc. is a Canadian pharmaceutical company focused on the development and distribution of medical products in the North American market. It was founded in 2018 and is headquartered in Toronto, Canada. HLS Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing HLS Therapeutics's Liabilities

HLS Therapeutics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating HLS Therapeutics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing HLS Therapeutics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

HLS Therapeutics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in HLS Therapeutics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about HLS Therapeutics stock

What is the level of liabilities of HLS Therapeutics this year?

HLS Therapeutics has a debt balance of 111.36 M USD this year.

What were the liabilities of HLS Therapeutics compared to the previous year?

The liabilities of HLS Therapeutics have increased by -4.25% dropped compared to the previous year.

What are the consequences of high debt for investors of HLS Therapeutics?

High liabilities can pose a risk for investors of HLS Therapeutics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in HLS Therapeutics?

Low liabilities mean that HLS Therapeutics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of HLS Therapeutics affect the company?

An increase in liabilities of HLS Therapeutics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of HLS Therapeutics affect the company?

A decrease in the liabilities of HLS Therapeutics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of HLS Therapeutics?

Some factors that can influence the liabilities of HLS Therapeutics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of HLS Therapeutics so important for investors?

The liabilities of HLS Therapeutics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can HLS Therapeutics take to modify the liabilities?

To change its liabilities, HLS Therapeutics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does HLS Therapeutics pay?

Over the past 12 months, HLS Therapeutics paid a dividend of 0.2 USD . This corresponds to a dividend yield of about 8.58 %. For the coming 12 months, HLS Therapeutics is expected to pay a dividend of 0.18 USD.

What is the dividend yield of HLS Therapeutics?

The current dividend yield of HLS Therapeutics is 8.58 %.

When does HLS Therapeutics pay dividends?

HLS Therapeutics pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of HLS Therapeutics?

HLS Therapeutics paid dividends every year for the past 0 years.

What is the dividend of HLS Therapeutics?

For the upcoming 12 months, dividends amounting to 0.18 USD are expected. This corresponds to a dividend yield of 7.9 %.

In which sector is HLS Therapeutics located?

HLS Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von HLS Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of HLS Therapeutics from 6/15/2023 amounting to 0.05 USD, you needed to have the stock in your portfolio before the ex-date on 4/27/2023.

When did HLS Therapeutics pay the last dividend?

The last dividend was paid out on 6/15/2023.

What was the dividend of HLS Therapeutics in the year 2023?

In the year 2023, HLS Therapeutics distributed 0.2 USD as dividends.

In which currency does HLS Therapeutics pay out the dividend?

The dividends of HLS Therapeutics are distributed in USD.